E-DRUG: Re: Policy process on re-evaluation of drugs

E-drug: Re: Policy process on re-evaluation of drugs
----------------------------------------------------------

Dear Friends,

We are just begun to work out a reevaluation system in China, but we only
have the materials of the "review" in UK and the "re-examination" in Japan.
Unfortunately, we even don't know how to get the Med-line or equivalent
CD-ROM Databases, or the details of other countries that have success in
implementing the reevaluation policy.

We will very appreciated to hear your comment or suggestion.

Best Regards,

  Wang Qing

Center for Drug Reevaluation of State Drug Administration
National Essential Drugs Division
Beijing, P.R.China
Building 11, Fa-Hua-Nan-Li, Chongwen District
TEL. +86-10-67164983
FAX. +44-10-67164984
Email: Cherry-qing@263.net

[Note from moderator: We have 3 subscribers in China and I am so happy to
have Wang participating actively! Here are Internet addresses to Free
Medline and Cochrane:
Free Medline
http://www.nlm.nih.gov/databases/freemedl.html

Centre for Evidence Based Medicine
http://cebm.jr2.ox.ac.uk/

Cochrane Collaboration
http://hiru.mcmaster.ca/COCHRANE/DEFAULT.HTM

Other E-druggers might suggest other sites?
Unfortunately, as Niyada mentioned, not much information on this particular
subject will be found there. Niyada, if you get any replies directly to you,
I would be pleased if you would share them with Wang. Kirsten Myhr]

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.